A responsible person is required to report serious adverse events associated with the use of cosmetic products in the U.S. to FDA within 15 business days.
The U.S. Food and Drug Administration (FDA) announced it will delay the enforcement of facility registration and product listing requirements under MoCRA for six months after the Dec. 29, 2023, deadline to give the industry "sufficient time" to submit.
The Modernization of Cosmetic Regulations Act of 2022 (MoCRA) is part of the Food and Drug Omnibus Reform Act of 2022 (FDORA) that President Biden signed into law late last year. MoCRA.
The U.S. Food and Drug Administration (FDA) announced it will delay the enforcement of facility registration and product listing requirements under MoCRA for six months after the Dec. 29, 2023, deadline to give the industry "sufficient time" to submit.